Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era Research Letter
| Authors: | Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; North, V. S.; Schòˆder, H.; Dogan, A.; Salles, G.; Yahalom, J.; Falchi, L. |
| Title: | Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era |
| Keywords: | multimodality cancer therapy; combined modality therapy; treatment; rituximab; antineoplastic agent; radiation; antineoplastic combined chemotherapy protocols; monoclonal antibody; lymphoma, large b-cell, diffuse; outcomes; orbit; diffuse large b cell lymphoma; antibodies, monoclonal, murine-derived; humans; human; ocular adnexa |
| Journal Title: | British Journal of Haematology |
| Volume: | 200 |
| Issue: | 4 |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2023-02-01 |
| Start Page: | 524 |
| End Page: | 527 |
| Language: | English |
| DOI: | 10.1111/bjh.18590 |
| PUBMED: | 36484627 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Lorenzo Falchi -- Export Date: 1 March 2023 -- Source: Scopus |
